Polyclonal Chicken GFP Antibody (clone IQGFP6 Polyclonal, WB)
Catalog Number: LS-C827997-50
50 µL (1 mg/mL) / $492.00
Antibody: Chicken Polyclonal
Applications: Enzyme-Linked Immunosorbent Assay, Western Blot
Format: Liquid
Human Colon: Formalin-Fixed, Paraffin-Embedded (FFPE)
IHC-plus™ Polyclonal Rabbit anti-Human TRIAP1 Antibody (IHC, IF, WB)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$383.00each
Catalog Number: LS-B14596-50
Catalog Number: LS-B14596
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- TRIAP1 antibody LS-B14596 is an unconjugated rabbit polyclonal antibody to human TRIAP1. Validated for IF, IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
- Application
- IF, IHC, IHC-P, WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This product carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- 15E1.1 | HSPC132 | MDM35 | WF-1 | p53CSV | Protein 15E1.1 | TRIAP1
- Recommended Dilution: IF/ICC
- 1:50 - 1:100
- Recommended Dilution: IHC
- 1:50 - 1:200
- Recommended Dilution: WB
- 1:500 - 1:2000
- NCBI GenBank
- NM_016399 | NP_057483.1
Target
- Target
- TRIAP1
- Antigen Species
- Human
- Specificity
- Human TRIAP1
- Epitope
- Human TRIAP1
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- Recombinant protein of human TRIAP1
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol
- Concentration
- 1.53 mg/mL
- Volume
- 50 Microliter
- Animal Free
- No
- Carrier-Free
- Yes
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
MicroRNA-18a inhibits ovarian cancer growth via directly targeting TRIAP1 and IPMK. Liu P, Qi X, Bian C, Yang F, Lin X, Zhou S, Xie C, Zhao X, Yi T. Oncology letters. 2017;13:4039-4046. PubMed: 28588697 PMC: PMC5452870
